Related Experiment Video
Updated: Jun 25, 2026
07:36
Isolation of Human Lymphatic Endothelial Cells by Multi-parameter Fluorescence-activated Cell Sorting
Published on: May 1, 2015
Pregnancy complicated by lymphangioleiomyomatosis
Soraya Saleh Gargari1, Sedigheh Hantoushzadae, Fourozan Mohamadi
1Feto-Maternal Unit, Mahdyeh Hospital, Shaheed Beheshti University of Medical Sciences, Tehran, Iran. Soraya_saleh2000@yahoo.co.uk
Archives of Iranian Medicine
|March 3, 2009
Summary
Lymphangioleiomyomatosis (LAM) is a rare lung disease. This case study shows a pregnant patient with LAM experienced mild symptoms despite high estrogen levels, suggesting pregnancy may not worsen the condition.
Area of Science:
- Pulmonology
- Reproductive Medicine
- Oncology
Background:
- Lymphangioleiomyomatosis (LAM) is a rare, progressive multisystem disorder.
- LAM is characterized by cystic lung lesions, potentially leading to respiratory failure.
- The condition is linked to sex hormones, with no effective treatments currently available.
Observation:
- A 35-year-old female patient, diagnosed with LAM, was in her second pregnancy.
- The patient had a history of five spontaneous pneumothorax events prior to pregnancy.
- Despite elevated estrogen levels during pregnancy, she experienced only mild, non-progressive exertional dyspnea.
Findings:
- The patient's respiratory status remained stable throughout her pregnancy.
- Exertional dyspnea did not limit her daily activities.
- LAM did not appear to deteriorate under the influence of increased estrogen during pregnancy.
Implications:
- Pregnancy may not necessarily lead to the deterioration of Lymphangioleiomyomatosis.
- Further research is needed to understand the interaction between LAM and hormonal changes during pregnancy.
- This case provides valuable insight into managing LAM patients during pregnancy.
